David D. Chism

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +11

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

Jeffrey S. Damrauer, Katherine A. Hoadley, David D. Chism et al. · Proceedings of the National Academy of Sciences · 2014 · 876 citations · Full text

Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

Timothy D. Gilligan, Daniel W. Lin, Rahul Aggarwal et al. · Journal of the National Comprehensive Cancer Network · 2019 · 440 citations

Surgical Oncology, Cancer Management, Gynecology +17

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Petros Grivas, Ali Raza Khaki, Trisha M. Wise‐Draper et al. · Annals of Oncology · 2021 · 321 citations · Full text

Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial

Toni K. Choueiri, James Larkin, Mototsugu Oya et al. · The Lancet Oncology · 2018 · 257 citations

Phase 1B, Urology, Oncology +7